We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
-1.93%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$34.3B
AUM Growth
+$648M
(+1.9%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
14.31%
Holding
3,015
New
907
Increased
756
Reduced
522
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$260M |
| 2 |
Boeing
BA
|
+$233M |
| 3 |
Arista Networks
ANET
|
+$207M |
| 4 |
Qiagen
QGEN
|
+$193M |
| 5 |
Kenvue
KVUE
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$365M |
| 2 |
AutoZone
AZO
|
+$239M |
| 3 |
Dominion Energy
D
|
+$186M |
| 4 |
Palo Alto Networks
PANW
|
+$185M |
| 5 |
Take-Two Interactive
TTWO
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.23% |
| 2 | Healthcare | 16.69% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Industrials | 8.79% |
| 5 | Energy | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PUT
XPeng
XPEV
$11.9B
| $38.8M | 0.11% |
+2,113,500
| New | +$35.9M |
|
227
Reinsurance Group of America
RGA
$15.5B
| $38.7M | 0.11% |
266,448
+226,046
| +559% | +$32M |
|
228
FTAI Aviation
FTAI
$22.9B
| $38.6M | 0.11% |
1,086,555
+600,872
| +124% | +$20.6M |
|
229
Xenon Pharmaceuticals
XENE
$6.01B
| $38.5M | 0.11% |
1,125,708
+977,500
| +660% | +$36.6M |
|
230
Steris
STE
$22.7B
| $38.4M | 0.11% |
175,130
+139,949
| +398% | +$31.7M |
|
231
Sunrun
RUN
$2.48B
| $38.3M | 0.11% |
3,050,722
+2,021,834
| +197% | +$33.2M |
|
232
Centene
CNC
$31.1B
| $38.1M | 0.11% |
553,384
+94,927
| +21% | +$6.32M |
|
|
PPLI
233
People Inc
PPLI
$3.16B
| $37.9M | 0.11% |
+917,054
| New | +$44.5M |
|
|
MRSH
234
Marsh
MRSH
$92.1B
| $37.8M | 0.11% |
198,707
-137,973
| -41% | -$26.4M |
|
235
Structure Therapeutics
GPCR
$3.41B
| $37.7M | 0.11% |
747,100
+316,100
| +73% | +$10.2M |
|
236
MasTec
MTZ
$21.1B
| $37.5M | 0.11% |
520,661
+28,661
| +6% | +$2.86M |
|
237
Chord Energy
CHRD
$7.78B
| $37.4M | 0.11% |
231,056
+171,556
| +288% | +$26.9M |
|
238
Sarepta Therapeutics
SRPT
$1.65B
| $37.3M | 0.11% |
307,343
-22,026
| -7% | -$2.49M |
|
239
Axsome Therapeutics
AXSM
$10.9B
| $37.2M | 0.11% |
531,937
+63,934
| +14% | +$4.78M |
|
|
AXNX
240
DELISTED
Axonics, Inc. Common Stock
AXNX
| $37M | 0.11% |
658,695
+600,821
| +1,038% | +$33.8M |
|
241
Celldex Therapeutics
CLDX
$2.96B
| $36.9M | 0.11% |
1,342,400
+157,600
| +13% | +$4.94M |
|
242
Micron Technology
MU
$930B
| $36.9M | 0.11% |
542,049
-2,282,951
| -81% | -$153M |
|
243
Maximus
MMS
$3.27B
| $36.8M | 0.11% |
493,300
+242,093
| +96% | +$19.7M |
|
244
Cogent Biosciences
COGT
$6.64B
| $36.7M | 0.11% |
3,766,755
-918,299
| -20% | -$10.9M |
|
245
McCormick & Company Non-Voting
MKC
$13.9B
| $36.7M | 0.11% |
485,406
+228,964
| +89% | +$19.1M |
|
246
News Corp Class A
NWSA
$15.1B
| $36.7M | 0.11% |
+1,827,200
| New | +$37.1M |
|
247
Hexcel
HXL
$7.78B
| $36.6M | 0.11% |
561,731
+561,327
| +138,942% | +$39.9M |
|
248
Pool Corp
POOL
$7B
| $36.4M | 0.11% |
+102,200
| New | +$37.2M |
|
249
Advanced Drainage Systems
WMS
$11.1B
| $36.3M | 0.11% |
318,638
-124,079
| -28% | -$15.1M |
|
|
CBAY
250
DELISTED
Cymabay Therapeutics
CBAY
| $36.2M | 0.11% |
+2,429,924
| New | +$32.2M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Point72 Asset Management held 3,015 positions worth $34.3B, up 1.9% from $33.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Point72 Asset Management deployed $1.94B of net new capital in Q3 2023, opening 907 new positions and adding to 756 existing holdings. Its largest new stake was Hologic: 1,902,507 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Adobe, an estimated $365M trimmed.
- Point72 Asset Management's largest Q3 2023 buy was Hologic: 1,902,507 shares worth $132M.
- Point72 Asset Management added most to Neurocrine Biosciences in Q3 2023, an estimated $260M increase.
- Point72 Asset Management's biggest Q3 2023 reduction was Adobe, cutting an estimated $365M.
- Point72 Asset Management fully exited Dominion Energy in Q3 2023, selling an estimated $186M.
- Point72 Asset Management's ten largest holdings make up 14% of its $34.3B portfolio in Q3 2023.
- Point72 Asset Management opened 907 new positions and closed 606 in Q3 2023.
- Point72 Asset Management's portfolio value rose 1.9% quarter-over-quarter to $34.3B.
Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.